Learning Center for the MDS Foundation
2019 ASH Registration

Orange County Convention Center
Room W308
Orlando, Florida
December 6, 2019
7:00 am – 11:00 am

Register Now

Seating is limited. Registration does not guarantee admission – please arrive early.

ACTIVITY OVERVIEW
This symposium will describe recent advances in our understanding of the genetic basis of myelodysplastic syndromes and related myeloid neoplasms, and how these advances are being translated into precision medicine approaches to diagnosis, prognostication and treatment for patients with these hematologic malignancies.

TARGET AUDIENCE
This activity is intended for physicians, oncology nurses, nurse practitioners, physician assistants, pharmacists and other health care professionals interested in the treatment and management of patients with Myelodysplastic Syndromes.

LEARNING OBJECTIVES

  • Identify how to use molecular genetics in diagnostic and prognostic evaluation of MDS
  • Discuss the fundamental concepts of inherited predisposition to myeloid neoplasms in general and myelodysplastic syndromes in particular
  • Identify how to diagnose and treat patients with MDS under the age of 60
  • Discuss how to diagnose CCUS
  • Discuss how to diagnose clonal monocytosis of clinical significance
  • Explain the molecular classification of MDS
  • Describe the prognostic significance of germline and somatic mutations in MDS
  • List current approaches to treatment of ineffective erythropoiesis in MDS
  • List current approaches to personalized treatment in MDS.

FACULTY

Mario Cazzola, MD – Symposium Co-Chair

Professor of Hematology
Department of Molecular Medicine, University of Pavia
Chief, Division of Hematology
Department of Hematology Oncology, Fondazione IRCCS Policlinico S. Matteo
Pavia, Italy

Stephen Nimer, MD – Symposium Co-Chair & MDSF Chairman

Director, Sylvester Comprehensive Cancer Center
Professor of Medicine, Biochemistry & Molecular Biology
University of Miami Miller School of Medicine
Miami, Florida, USA

Catherine Cargo, MD

St. James’s University Hospital
Haematological Malignancy Diagnostic Service
Leeds, United Kingdom

Jane Churpek, MD

Medical Director, Comprehensive Cancer Risk
and Prevention Program
University of Chicago Medicine
Chicago, Illinois, USA

Eva Hellström Lindberg, MD, PhD

Professor of Hematology
Karolinska Institute at Karolinska University Hospital Huddinge
Stockholm, Sweden

Luca Malcovati, MD

Associate Professor of Hematology
Department of Molecular Medicine
University of Pavia
Department of Hematology Oncology
Fondazione IRCCS Policlinico San Matteo
Pavia, Italy

Elli Papaemmanuil, PhD

Assistant Professor Computational Oncology Service at
Memorial Sloan Kettering
New York City, New York, USA

AGENDA

7:30 – 7:35 am Welcome – About the MDS Foundation, Inc.
Stephen Nimer
7:35 – 7:40 am Program Overview and Objectives
Mario Cazzola
7:40 – 8:15 am MDS Under the Age of 50
Jane Churpek
8:15 – 8:50 am CCUS and Clonal Monocytosis of Clinical Significance
Catherine Cargo
8:50 – 9:25 am Classification and Personalized Prognosis in MDS
Elli Papaemmanuil
9:25 – 10:00 am Ineffective Erythropoiesis in MDS
Eva Hellström Lindberg
10:00 – 10:35 am Targeted Treatment in MDS
Luca Malcovati
10:35 – 11:00am Questions/Answers/Discussion

CRITERIA FOR SUCCESS

Statements of credit will be awarded based on the participant’s attendance, participation in the pre/post-test and submission of the activity evaluation form. A statement of credit will be available upon completion of an online evaluation/claimed credit form at https://www.mds-foundation.org/learning-center/mds-2019/. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this CME/CE activity, please contact AKH Inc. at tbrignoni@akhcme.com.

ACCREDITATION

AKH LOGO
CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare

PHYSICIANS

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and the Myelodysplastic Syndromes Foundation, Inc. (MDSF). AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PHYSICIAN ASSISTANTS

NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

PHARMACY

ACPE LOGO

AKH, Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AKH, Inc., Advancing Knowledge in Healthcare approves this knowledge-based activity for 3.5 contact hour(s) (0.35 CEUs). UAN 0077-9999-19-045-L04-P.

NURSING

AKH, Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 3.5 Contact Hours.

Activity is jointly-provided by AKH Inc., Advancing Knowledge in Healthcare and the Myelodysplastic Syndromes Foundation, Inc. (MDSF).

COMMERCIAL SUPPORT

Full notification of commercial support will be provided in the final program.

AMERICANS WITH DISABILITIES ACT

AKH Inc, Advancing Knowledge in Healthcare fully intends to comply with the legal requirements of the Americans with Disabilities Act. If you need assistance, please notify AKH at 904-683-8843 at least two weeks prior to the activity.

*Activity and faculty subject to change

 

Register Now

 

Seating is limited. Registration does not guarantee admission – please arrive early.

Message Board
Review answers to commonly asked questions or get answers to your questions from an MDS expert